ALX Oncology Inc. (ALXO)
1.61
0.02 (1.26%)
At close: Jan 15, 2025, 9:46 AM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Revenue | n/a | n/a | n/a | 1.18M | 4.80M | 2.07M |
| Cost of Revenue | 836.00K | 1.47M | 736.00K | 1.07M | 4.36M | 1.88M |
| Gross Profit | -836.00K | -1.47M | -736.00K | 107.00K | 436.00K | 187.00K |
| Operating Income | -170.28M | -127.44M | -83.56M | -43.66M | -19.18M | -13.68M |
| Interest Income | 10.65M | 4.04M | 91.00 | 124.00K | 21.00 | n/a |
| Pretax Income | -160.81M | -123.42M | -83.48M | -45.50M | -19.21M | -13.69M |
| Net Income | -160.81M | -123.48M | -83.46M | -45.74M | -19.24M | -13.73M |
| Selling & General & Admin | 28.48M | 29.04M | 23.39M | 14.81M | 3.31M | 2.60M |
| Research & Development | 141.79M | 98.40M | 60.17M | 28.96M | 16.31M | 11.27M |
| Other Expenses | n/a | -260.00K | 84.00K | -404.00K | -5.00K | -2.00K |
| Operating Expenses | 170.28M | 127.44M | 83.56M | 43.77M | 19.62M | 13.87M |
| Interest Expense | 1.56M | n/a | 13.00K | 811.00K | 21.00K | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 170.28M | 127.44M | 83.56M | 44.84M | 23.98M | 15.75M |
| Income Tax | n/a | 64.00K | -21.00K | 241.00K | 34.00K | 45.00K |
| Shares Outstanding (Basic) | 42.99M | 40.70M | 40.31M | 39.84M | 36.49M | 21.95M |
| Shares Outstanding (Diluted) | 42.99M | 40.70M | 40.31M | 39.84M | 36.49M | 21.95M |
| EPS (Basic) | -3.74 | -3.03 | -2.07 | -1.15 | -0.53 | -0.63 |
| EPS (Diluted) | -3.74 | -3.03 | -2.07 | -1.15 | -0.53 | -0.63 |
| EBITDA | -158.40M | -121.95M | -83.47M | -43.46M | -18.76M | -13.26M |
| Depreciation & Amortization | 836.00K | 1.47M | 736.00K | 202.00K | 429.00K | 431.00K |